2019
DOI: 10.1172/jci125015
|View full text |Cite
|
Sign up to set email alerts
|

CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 92 publications
1
18
0
Order By: Relevance
“…This suggests that the major epigenetic changes acquired during replication can be reset to some extent. While reprogramming represents an exciting regenerative prospect in the aging field, some issues remain-namely the propensity for incidence of teratomas when reprogramming is conducted in vivo [56,57]. However, partial reprogramming without dedifferentiation may provide a path forward and it will be important to determine whether resetting of the replication signature also occurs under those circumstances.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that the major epigenetic changes acquired during replication can be reset to some extent. While reprogramming represents an exciting regenerative prospect in the aging field, some issues remain-namely the propensity for incidence of teratomas when reprogramming is conducted in vivo [56,57]. However, partial reprogramming without dedifferentiation may provide a path forward and it will be important to determine whether resetting of the replication signature also occurs under those circumstances.…”
Section: Discussionmentioning
confidence: 99%
“…GO and KEGG pathway enrichment analyses demonstrated that these DEmRNAs mainly serve as regulators of porcine GC states and functions. For instance, CDK6 , CDK18 , CDKN2B , CDKN2C , CCNB1 , CCNJ , and CCNK are associated with cell cycle [4345]. BMP2 , GDF15 , TGF-β1 , SMAD5 , and PCNA are involved in cell proliferation [46, 47].…”
Section: Discussionmentioning
confidence: 99%
“…Taken together, FMOD administration in adult wound models elicits a similar phenotype to fetal wounds at the molecular, cellular, and gross morphological levels (Zheng et al, 2017). Moreover, recent studies demonstrate that FMOD can directly reprogram human dermal fibroblasts into a multipotent stage, indicating its ability to regulate the intracellular signaling cascade and determine the cell fate (Zheng et al, 2012;Li et al, 2016;Zheng et al, 2019). Furthermore, from a translational aspect, recent studies have confirmed the biopotency of FMOD in reducing scar formation, accelerating wound tensile strength reestablishment, and improving dermal collagen architecture organization as well as gross wound appearance in multiple small and large preclinical animal models, and even within an excessive-mechanical-loading model (Zheng et al, 2017;Jiang et al, 2018), highlighting the enormous potentials of FMOD as a regenerative medicine for wound and scar therapies.…”
Section: Fibroblast Activitiesmentioning
confidence: 95%